Figures and Tables

From the following article:

Can open-source R&D reinvigorate drug research?

Bernard Munos

Nature Reviews Drug Discovery 5, 723-729 (September 2006)

doi:10.1038/nrd2131

Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Portfolio of the Medicines for Malaria Venture.

Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Public–private partnerships engaged in drug and vaccine development

Table 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 2

Public–private partnerships and their partners

Table 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 3

Public–private partnerships lower the critical mass required to discover and develop new cures

Table 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 4

R&D costs for public–private partnerships (US$ million)